UCB Awards $150K in Scholarships to Myasthenia Gravis Patients and Caregivers
Event summary
- UCB awarded 15 scholarships to U.S. individuals impacted by myasthenia gravis (MG) or supporting loved ones with the disease.
- Recipients include patients and caregivers pursuing education in healthcare, science, engineering, public health, social work, and advocacy.
- Selection committee comprised of MG-impacted individuals and neuromuscular disease specialists.
- Scholarship program aims to reduce financial burdens associated with higher education for the MG community.
The big picture
UCB's scholarship initiative reflects a broader trend among biopharmaceutical companies investing in patient support beyond drug development. By empowering the MG community through education, UCB strengthens its position as a leader in rare disease care while potentially fostering long-term loyalty and advocacy.
What we're watching
- Community Engagement
- How UCB's scholarship program will affect its reputation and relationships within the MG community.
- Patient Advocacy
- Whether the recipients' advocacy efforts will amplify awareness of MG and rare diseases.
- Educational Impact
- The pace at which scholarship-funded education leads to career advancements in healthcare and related fields.